Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Neogen (NEOG)

Neogen Names Mikhael Nassif President and CEO Effective August 11, 2025

Neutral Impact 4 of 5 leadership Written later

Neogen Corporation appointed Mikhael Nassif as President and Chief Executive Officer, effective August 11, 2025. Nassif most recently served as Global President of Point-of-Care Diagnostics at Siemens Healthineers, and his offer includes a $800,000 base salary and a $4,500,000 target long-term incentive grant.

Key points

  • Mikhael Nassif, age 49, becomes CEO effective August 11, 2025, joining from Siemens Healthineers where he served as Global President of Point-of-Care Diagnostics since September 2022.
  • Base salary is $800,000, with an annual bonus target of 100% of base salary under the Incentive Compensation Plan.
  • Sign-on equity grant of $2,000,000 (50% stock options, 50% RSUs) and a one-time cash award of $500,000 payable by September 5, 2025, subject to repayment if employment ends within one year.

The filing

CompanyNeogen (NEOG)
Form8-K, current report
Filed with the SECJul 24, 2025, 9:04 AM ET
Accession number0000950170-25-098159

Items reported: 5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.